Although, many studies reveal the vital role of CK2 in cancer cell proliferation and survival [11], and its activation is shown to inhibit the transcriptional activity of stimulatory protein-1 (SP-1) by suppressing its DNA binding activity through phosphorylation of the carboxy-terminal domain of SP-1 [12]. The gene discussed is SP1; the disease is cancer.